Structure Function Claims News Today

Scientists and federal agencies should redefine what it means to be healthy to substantiate structure-function claims for nutraceuticals, according to a perspective published in the Journal of Dietary Supplements.

Despite language in the 2022 Health Products Compliance Guidance around the need for clinical trials to substantiate health claims, the US Federal Trade Commission has stated that not all claims require that level of substantiation.

A new report titled "Health Claims and Doses of Fish Oil Supplements in the US" that was published in JAMA Cardiology suggests that most fish oil supplement labels make claims about health benefits without trial data to support their efficacy. CRN weighs in.

A new paper in JAMA Cardiology that criticizes the use of structure/function claims on omega-3 dietary supplements is “fraught with inaccuracies and never should have made it through the peer review process”, says the Global Organization for EPA and DHA Omega-3s (GOED).

A new paper in JAMA Cardiology that criticizes the use of structure/function claims on omega-3 dietary supplements is “fraught with inaccuracies and never should have made it through the peer review process”, says the Global Organization for EPA and DHA Omega-3s (GOED).

As supplements to support women’s health increase in the marketplace, marketers need to understand what they can and cannot say regarding claims relating to PMS relief, menopause symptoms, reproductive health, and more.

Appeal court reaffirms validity of structure/function claims in biotin lawsuit An appellate court ruling that reaffirms the validity of structure/function claims is good news for the dietary supplement industry, an attorney says. Katie Bond, who is now with the law firm Lathrop GPM, said the ruling came in a case brought against Target and contract manufacturer International Vitamin Corporation and concerned structure/function claims for the ingredient biotin, which ...